3Creager MA,Luscher TF,Cosentino F,et al.Diabetes and vascular disease:pathophysiology,clinical consences,and medical therapy:Part Ⅰ[J].Circulation,2003;108(12):1527-32.
4Goligorsky MS.Endothelial cell dysfunction:can't live with it,how to live without it[J].Am J Physiol Renal Physiol,2005;288(5):871-80.
5Maruyoshi H,Kojima S,Funahashi T,et al.Adiponectin is inversely related to plasminogen activator inhibitor type 1 in patients with stable exertional angina[J].Thromb Haemost,2004;91(5):1026-30.
6Shen GX.Impact and mechanism for oxidized and glycated lipoproteins on genenaion of fibrinolytic regulators from vascular endothelial cells[J].Mol Cell Biochem,2003;246(1-2):69-74.
7Ren S,Lee H,Hu L,et al.lmpact of diabetes-associated lipoproteins on generation of fibrinolytic regulators from vascular endothelial cell[J].J Clin Endocrinol Metab,2002;87(1):286-91.
8Chen J,Brodsky S,Li H,et al.Delayed branching of endothelial caprilary-lide cords in glycated collagen Ⅰ is mediated by early induction of PAI-1[J].Am J Physiol tenal Physiol,2001;281(1):71-80.
9Ren S,Shen GX.Impact of antioxidants and HDL on glycated LDL-induced genemtion of fibrinolytic regulators from vaascualr endothelial cells[J].Arterioscler Thromb Vasc Biol,2000;20(6):1688-93.
10Maruyama L Coagulation/fibrinolytic system and platelet in acute coronary syndrome[J].Nippon Rinsho,1998,56(10):2488-92.
